While SATB1 and TCF7 were the only two PcG target genes that showed significant dysregulation in BOS, a total of 18 out of the 40 target genes were significantly dysregulated in AML-ASXL1. This evidence concerns the gene ASXL1 and acute myeloid leukemia.